{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:11:04Z","timestamp":1770919864461,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:00:00Z","timestamp":1496793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["105A1-MGPP11-014"],"award-info":[{"award-number":["105A1-MGPP11-014"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["04D2-MMMOST12"],"award-info":[{"award-number":["04D2-MMMOST12"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["05D2-MMMOST24"],"award-info":[{"award-number":["05D2-MMMOST24"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178937","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T13:33:45Z","timestamp":1496842425000},"page":"e0178937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model"],"prefix":"10.1371","volume":"12","author":[{"given":"Kai-Ti","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Pin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-I","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"AM Karst","year":"2010","journal-title":"J Oncol"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"R Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2009.09.018","article-title":"Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma","volume":"116","author":"K Matsuo","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signaling in health and disease","volume":"34","author":"M Kadmiel","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/oxfordjournals.annonc.a010806","article-title":"Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel","volume":"7","author":"A Gennari","year":"1996","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"ref7","article-title":"New dimension of glucocorticoids in cancer treatment","author":"KT Lin","year":"2016","journal-title":"Steroids"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1038\/ncomms6917","article-title":"Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B","volume":"6","author":"KT Lin","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"KF Roby","year":"2000","journal-title":"Carcinogenesis"},{"issue":"22","key":"ref10","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1158\/0008-5472.CAN-05-1822","article-title":"SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells","volume":"65","author":"JA George","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1535-7163.MCT-08-0864","article-title":"ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer","volume":"8","author":"J Greenaway","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-0-387-68969-2_14","article-title":"Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax","volume":"622","author":"KF Roby","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2007.10.035","article-title":"Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer","volume":"108","author":"J Greenaway","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)64505-1","article-title":"Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma","volume":"161","author":"L Zhang","year":"2002","journal-title":"Am J Pathol"},{"issue":"20","key":"ref15","doi-asserted-by":"crossref","first-page":"17638","DOI":"10.1074\/jbc.M111575200","article-title":"Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes","volume":"277","author":"P Sachdev","year":"2002","journal-title":"The Journal of biological chemistry"},{"issue":"19","key":"ref16","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1158\/0008-5472.CAN-11-0073","article-title":"MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells","volume":"71","author":"S Saini","year":"2011","journal-title":"Cancer research"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/0008-5472.CAN-12-0540","article-title":"miRNA-708 control of CD44(+) prostate cancer-initiating cells","volume":"72","author":"S Saini","year":"2012","journal-title":"Cancer research"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccr.2012.11.019","article-title":"Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration","volume":"23","author":"S Ryu","year":"2013","journal-title":"Cancer Cell"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ceb.2009.06.004","article-title":"Control of cell adhesion dynamics by Rap1 signaling","volume":"21","author":"B Boettner","year":"2009","journal-title":"Current opinion in cell biology"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2011.12.004","article-title":"Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor","volume":"134","author":"AR Clark","year":"2012","journal-title":"Pharmacology & therapeutics"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"K De Bosscher","year":"2003","journal-title":"Endocrine reviews"},{"issue":"1\u20132","key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cytogfr.2007.01.005","article-title":"Glucocorticoids in the regulation of transcription factors that control cytokine synthesis","volume":"18","author":"AC Liberman","year":"2007","journal-title":"Cytokine & growth factor reviews"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/ijc.25757","article-title":"Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor","volume":"129","author":"AM Orengo","year":"2011","journal-title":"Int J Cancer"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1158\/0008-5472.CAN-11-0993","article-title":"IL-18 induces PD-1-dependent immunosuppression in cancer","volume":"71","author":"M Terme","year":"2011","journal-title":"Cancer Res"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.4049\/jimmunol.1401282","article-title":"IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells","volume":"193","author":"HX Lim","year":"2014","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","article-title":"IL-1, IL-18, and IL-33 families of cytokines","volume":"223","author":"WP Arend","year":"2008","journal-title":"Immunol Rev"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"K Schroder","year":"2010","journal-title":"Cell"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.2224","article-title":"Inflammasomes in carcinogenesis and anticancer immune responses","volume":"13","author":"L Zitvogel","year":"2012","journal-title":"Nat Immunol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"BZ Qian","year":"2010","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-065X.2008.00602.x","article-title":"Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells","volume":"222","author":"I Marigo","year":"2008","journal-title":"Immunol Rev"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","article-title":"Tumor microenvironment: The culprit for ovarian cancer metastasis?","volume":"377","author":"Z Luo","year":"2016","journal-title":"Cancer Lett"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/1541-7786.MCR-12-0353","article-title":"Revisiting the complexity of the ovarian cancer microenvironment\u2014clinical implications for treatment strategies","volume":"10","author":"N Musrap","year":"2012","journal-title":"Mol Cancer Res"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK","volume":"175","author":"T Hagemann","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","article-title":"Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2","volume":"39","author":"TX Cui","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"ref36","first-page":"551","article-title":"Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas","volume":"28","author":"C Zhang","year":"2006","journal-title":"International journal of oncology"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ijc.21743","article-title":"Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors","volume":"119","author":"M Sui","year":"2006","journal-title":"Int J Cancer"},{"issue":"21","key":"ref38","first-page":"2902","article-title":"Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice","volume":"17","author":"WJ Hou","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/cncr.20534","article-title":"Glucocorticoid administration in antiemetic therapy: is it safe?","volume":"101","author":"K Munstedt","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1213\/ANE.0b013e3182a5d656","article-title":"Is dexamethasone associated with recurrence of ovarian cancer?","volume":"118","author":"GS De Oliveira Jr.","year":"2014","journal-title":"Anesth Analg"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3949\/ccjm.59.5.505","article-title":"Glucocorticoids in clinical oncology","volume":"59","author":"D Walsh","year":"1992","journal-title":"Cleveland Clinic journal of medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T16:25:33Z","timestamp":1540311933000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178937"}},"subtitle":[],"editor":[{"given":"Daotai","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}